Efficacy of hyperbaric oxygen treatment for... (2013 study) Skip to main content
Study Exp Ther Med 2013

Efficacy of hyperbaric oxygen treatment for depression in the convalescent stage following cerebral hemorrhage

Cao H, Ju K, Zhong L, Meng T, Exp Ther Med, 2013

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers compared hyperbaric oxygen (HBO) treatment with a medication called Deanxit in people who had depression 2 to 6 months after bleeding in the brain (cerebral hemorrhage).

What They Found

In this randomized study of 60 patients with depression after cerebral hemorrhage, HBO and Deanxit both lowered depression scores, and the two groups differed significantly in total efficacy and in Hamilton Depression Scale (HAMD) scores (p less than 0.05 for each). Thirty patients received HBO and 30 received Deanxit. Depression and nerve function defect scores were measured before treatment and at 4 weeks after treatment. HAMD scores improved significantly within each group from before to after treatment (p less than 0.05 for both). The abstract does not say which group improved more, and it gives no HAMD score values.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was small (60 patients), followed people for only 4 weeks, and the abstract gives no HAMD score values, no HBO pressure or session details, and no direction for the difference between groups.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 23837040
Year Published 2013
Journal Exp Ther Med

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology